Clinical Exome Sequencing(CES)_ONCO With MCC

Clinical Exome Sequencing (CES) – ONCO with MCC

🧬 Comprehensive Cancer Genetic Analysis

Clinical Exome Sequencing (CES) – ONCO with MCC is an advanced genomic test that analyzes thousands of cancer-related genes to identify genetic alterations associated with various cancers. The MCC (Molecular Clinical Correlation) component helps interpret results for accurate clinical decision-making.

Why is this test important?

✅ Detects cancer-causing genetic mutations
✅ Supports diagnosis and classification of tumors
✅ Helps identify targeted therapy options
✅ Assists in prognosis and treatment planning
✅ Provides valuable information for precision oncology

Recommended for:

🔹 Patients with suspected hereditary cancers
🔹 Individuals with complex or rare cancer cases
🔹 Patients requiring personalized cancer treatment strategies
🔹 Oncologists seeking detailed molecular insights

Sample Required:

🩸 Blood / Tumor Tissue (as advised by the clinician)

Benefits:

✔ Comprehensive analysis of cancer-associated genes
✔ High-throughput next-generation sequencing (NGS) technology
✔ Detailed molecular interpretation with clinical correlation
✔ Enables personalized and targeted treatment approaches

Early genetic insights can help guide better cancer management and treatment decisions.

#ClinicalExomeSequencing #CancerGenetics #PrecisionOncology #GeneticTesting #CancerDiagnosis #NGSTesting #MolecularDiagnostics #AdvancedHealthcare #Dermafact #gynofact